NPH Neuropharm

 

TIDMLLOY TIDMNPH 
 
RNS Number : 8844I 
Lloyds Banking Group PLC 
19 March 2010 
 
                                                                        FORM 8.3 
 
    DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 
                        (Rule 8.3 of the Takeover Code) 
 
1.         KEY INFORMATION 
 
+--------------------------------+-------------------------------------+ 
| Name of person dealing  (Note  | Lloyds Banking Group plc and its    | 
| 1)                             | subsidiaries                        | 
+--------------------------------+-------------------------------------+ 
| Company dealt in               | Neuropharm Group plc                | 
+--------------------------------+-------------------------------------+ 
| Class of relevant security to  | Ordinary 10p                        | 
| which the dealings being       |                                     | 
| disclosed relate (Note 2)      |                                     | 
+--------------------------------+-------------------------------------+ 
| Date of dealing                | 18 March 2010                       | 
+--------------------------------+-------------------------------------+ 
 
2.         INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE 
 
(a) Interests and short positions (following dealing) in the class of relevant 
security dealt in (Note 3) 
 
+----------------------------+-----------+----------+--------+--------+ 
|                            | Long      |          | Short  |        | 
+----------------------------+-----------+----------+--------+--------+ 
|                            | Number    | (%)      | Number | (%)    | 
+----------------------------+-----------+----------+--------+--------+ 
| (1) Relevant securities    | 2,970,074 | (9.418%) |        |        | 
+----------------------------+-----------+----------+--------+--------+ 
| (2) Derivatives (other     |           |          |        |        | 
| than options)              |           |          |        |        | 
+----------------------------+-----------+----------+--------+--------+ 
| (3) Options and agreements |           |          |        |        | 
| to purchase/sell           |           |          |        |        | 
+----------------------------+-----------+----------+--------+--------+ 
| Total                      | 2,970,074 | (9.418%) |        |        | 
+----------------------------+-----------+----------+--------+--------+ 
 
 
(b) Interests and short positions in relevant securities of the company, other 
than the class dealt in (Note 3) 
 
+----------------------------+--------+--------+--------+-----+ 
| Class of relevant          | Long   |        | Short  |     | 
| security:                  |        |        |        |     | 
+----------------------------+--------+--------+--------+-----+ 
|                            | Number | (%)    | Number | (%) | 
+----------------------------+--------+--------+--------+-----+ 
| (1) Relevant securities    |        |        |        |     | 
+----------------------------+--------+--------+--------+-----+ 
| (2) Derivatives (other     |        |        |        |     | 
| than options)              |        |        |        |     | 
+----------------------------+--------+--------+--------+-----+ 
| (3) Options and agreements |        |        |        |     | 
| to purchase/sell           |        |        |        |     | 
+----------------------------+--------+--------+--------+-----+ 
| Total                      |        |        |        |     | 
+----------------------------+--------+--------+--------+-----+ 
 
(c)        Rights to subscribe (Note 3) 
 
+--------------------+----------------------------+ 
| Class of relevant  | Details                    | 
| security:          |                            | 
+--------------------+----------------------------+ 
|                    |                            | 
+--------------------+----------------------------+ 
 
3.         DEALINGS (Note 4) 
 
(a)        Purchases and sales 
 
+-------------------------+----------------------+------------+ 
| Purchase/sale           | Number of securities | Price per  | 
|                         |                      | unit (Note | 
|                         |                      | 5)         | 
+-------------------------+----------------------+------------+ 
| Sale                    | 58,600               | GBP0.100   | 
+-------------------------+----------------------+------------+ 
|                         |                      |            | 
+-------------------------+----------------------+------------+ 
|                         |                      |            | 
+-------------------------+----------------------+------------+ 
|                         |                      |            | 
+-------------------------+----------------------+------------+ 
 
 
(b)        Derivatives transactions (other than options) 
 
+-----------+------------+---------------+-------------+ 
| Product   | Long/short | Number of     | Price per   | 
| name,     | (Note 6)   | securities    | unit  (Note | 
| e.g. CFD  |            | (Note 7)      | 5)          | 
|           |            |               |             | 
+-----------+------------+---------------+-------------+ 
|           |            |               |             | 
+-----------+------------+---------------+-------------+ 
(c)        Options transactions in respect of existing securities 
(i)         Writing, selling, purchasing or varying 
 
+-----------+-------------+------------+----------+-----------+--------+---------------+ 
| Product   | Writing,    | Number     | Exercise | Type,     | Expiry | Option        | 
| name,e.g. | selling,    | of         | price    | e.g.      | date   | money         | 
| call      | purchasing, | securities |          | American, |        | paid/received | 
| option    | varying     | to which   |          | European  |        | per unit      | 
|           | etc.        | the option |          | etc.      |        | (Note 5)      | 
|           |             | relates    |          |           |        |               | 
|           |             | (Note 7)   |          |           |        |               | 
+-----------+-------------+------------+----------+-----------+--------+---------------+ 
|           |             |            |          |           |        |               | 
+-----------+-------------+------------+----------+-----------+--------+---------------+ 
 
(ii)        Exercising 
 
+----------+--------------+--------------------+ 
| Product  | Number of    | Exercise price per | 
| name,    | securities   | unit (Note 5)      | 
| e.g.     |              |                    | 
| call     |              |                    | 
| option   |              |                    | 
+----------+--------------+--------------------+ 
|          |              |                    | 
+----------+--------------+--------------------+ 
 
(d)        Other dealings (including new securities) (Note 4) 
 
+--------------------+------------+-------------+ 
| Nature of          | Details    | Price per   | 
| transaction (Note  |            | unit (if    | 
| 8)                 |            | applicable) | 
|                    |            | (Note 5)    | 
+--------------------+------------+-------------+ 
|                    |            |             | 
+--------------------+------------+-------------+ 
 
4.         OTHER INFORMATION 
 
Agreements, arrangements or understandings relating to options or derivatives 
 
Full details of any agreement, arrangement or understanding between the person 
disclosing and any other person relating to the voting rights of any relevant 
securities under any option referred to on this form or relating to the voting 
rights or future acquisition or disposal of any relevant securities to which any 
derivative referred to on this form is referenced.  If none, this should be 
stated. 
 
.............................................................................. 
N/A 
.............................................................................. 
Is a Supplemental Form 8 attached? (Note 9) 
           NO 
 
 
+------------------------------+-----------------+ 
| Date of disclosure           | 19 March 2010   | 
+------------------------------+-----------------+ 
| Contact name                 | Matthew Wilson  | 
+------------------------------+-----------------+ 
| Telephone number             | 0113 235 7729   | 
+------------------------------+-----------------+ 
| If a connected EFM, name of  |                 | 
| offeree/offeror with which   |                 | 
| connected                    |                 | 
+------------------------------+-----------------+ 
| If a connected EFM, state    |                 | 
| nature of connection (Note   |                 | 
| 10)                          |                 | 
+------------------------------+-----------------+ 
Notes 
The Notes on Form 8.3 can be viewed on the Takeover Panel's website 
at www.thetakeoverpanel.org.uk 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RETJLMATMBMBBBM 
 

Neuropharm (LSE:NPH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

Neuropharm (LSE:NPH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024